Women's College Research Institute, Women's College Hospital, 76 Grenville Street, Toronto, M5S 1B2, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Breast Cancer Res Treat. 2018 May;169(1):9-23. doi: 10.1007/s10549-017-4644-3. Epub 2018 Jan 20.
To review the empirical evidence to support the conventional (sequential) model of breast cancer progression, which is based on the paradigm that cancer passes through several stages, including an in situ stage prior to an invasive stage, and thereafter (in some cases) disseminates to the lymph nodes and distant organs.
We review the cancer literature of the last 50 years which relates to the prevention of invasive breast cancer (through radiotherapy or surgery) and reductions in the mortality for breast cancer.
For both invasive cancers and DCIS, the literature indicates that prevention of in-breast invasive recurrences does not prevent death from breast cancer. Moreover, the presence of residual cancer cells in the breast after breast-conserving surgery does not compromise the cure rate.
We propose an alternate (parallel) model of breast cancer wherein there is a small pool of cancer stem cells which have metastatic potential from their inception and which disseminate synchronously through several routes-to the breast stroma, to the lymph nodes and to distant organs. Cancer cells which disseminate to the breast give rise to cells which make up the bulk of the tumour mass but these are not the source of the distant metastases.
回顾支持乳腺癌进展传统(序贯)模型的经验证据,该模型基于癌症经历多个阶段的范例,包括侵袭前的原位阶段,然后(在某些情况下)扩散到淋巴结和远处器官。
我们回顾了过去 50 年与预防侵袭性乳腺癌(通过放疗或手术)和降低乳腺癌死亡率相关的癌症文献。
对于浸润性癌和 DCIS,文献表明,预防乳腺内侵袭性复发并不能预防乳腺癌死亡。此外,保乳手术后乳腺内残留癌细胞的存在并不影响治愈率。
我们提出了一种替代(平行)的乳腺癌模型,其中存在一小群具有转移潜能的癌症干细胞,从其起源开始就具有转移潜能,并通过多种途径同步扩散-到乳腺基质、淋巴结和远处器官。播散到乳腺的癌细胞会产生构成肿瘤大部分的细胞,但这些不是远处转移的来源。